Paper
0
Safety/efficacy of atezolizumab + bevacizumab during anti‐platelet/anticoagulation therapy in unresectable hepatocellular carcinoma
Authors
Michihisa Moriguchi,K Okuda
Go Horiguchi,Seita Kataoka,Yuya Seko,Kanji Yamaguchi,Takeshi Nishimura,Hideki Fujii,Yasuhide Mitsumoto,Masami Miyagawa,Toshihiko Kirishima,Shinya Okishio,Tasuku Hara,Hiroki Ishikawa,Yasuyuki Nagao,Masayasu Jo,Michiaki Ishii,Saiyu Tanaka,Norihito Yamauchi,Hironori Mitsuyoshi,Tomoki Nakajima,Hiroyoshi Taketani,Kota Yano,Masahiro Arai,Atsushi Umemura
+23 authors
,Tomohisa TakagiJournal
Published
Jun 4, 2024
Show more
Save
Tip0
TipSave
Abstract
This study aimed to determine the safety and efficacy of atezolizumab + bevacizumab therapy in hepatocellular carcinoma patients receiving anti-platelet agents or anticoagulants.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.